|
1
|
Friedman HS, Kerby T and Calvert H:
Temozolomide and treatment of malignant glioma. Clin Cancer Res.
6:2585–2597. 2000.PubMed/NCBI
|
|
2
|
Mrugala MM and Chamberlain MC: Mechanisms
of disease: Temozolomide and glioblastoma-look to the future. Nat
Clin Pract Oncol. 5:476–486. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Agarwala SS and Kirkwood JM: Temozolomide,
a novel alkylating agent with activity in the central nervous
system, may improve the treatment of advanced metastatic melanoma.
Oncologist. 5:144–151. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stevens MF, Hickman JA, Stone R, Gibson
NW, Baig GU, Lunt E and Newton CG: Antitumor imidazotetrazines. 1.
Synthesis and chemistry of
8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3, 5-tetrazin-4(3
H)-one, a novel broad-spectrum antitumor agent. J Med Chem.
27:196–201. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fulda S: Cell death-based treatment of
glioblastoma. Cell Death Dis. 9:1212018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen PH, Shen WL, Shih CM, Ho KH, Cheng
CH, Lin CW, Lee CC, Liu AJ and Chen KC: The CHAC1-inhibited Notch3
pathway is involved in temozolomide-induced glioma cytotoxicity.
Neuropharmacology. 116:300–314. 2017. View Article : Google Scholar
|
|
7
|
Oshiro S, Tsugu H, Komatsu F, Ohmura T,
Ohta M, Sakamoto S, Fukushima T and Inoue T: Efficacy of
temozolomide treatment in patients with high-grade glioma.
Anticancer Res. 29:911–917. 2009.PubMed/NCBI
|
|
8
|
van den Bent MJ: Adjuvant treatment of
high grade gliomas. Ann Oncol. 17(Suppl 10): x186–x190. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen W, Hu JA and Zheng JS: Mechanism of
temozolomide-induced antitumour effects on glioma cells. J Int Med
Res. 42:164–172. 2014. View Article : Google Scholar
|
|
10
|
Barciszewska AM, Gurda D, Głodowicz P,
Nowak S and Naskręt-Barciszewska MZ: A new epigenetic mechanism of
temozolomide action in glioma cells. PLoS One. 10:e01366692015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cai X and Sughrue ME: Glioblastoma: New
therapeutic strategies to address cellular and genomic complexity.
Oncotarget. 9:9540–9554. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang J, Stevens MF and Bradshaw TD:
Temozolomide: Mechanisms of action, repair and resistance. Curr Mol
Pharmacol. 5:102–114. 2012. View Article : Google Scholar
|
|
13
|
Johannessen TC and Bjerkvig R: Molecular
mechanisms of temozolomide resistance in glioblastoma multiforme.
Expert Rev Anticancer Ther. 12:635–642. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan Y, Xu Z, Dai S, Qian L, Sun L and Gong
Z: Targeting autophagy to sensitive glioma to temozolomide
treatment. J Exp Clin Cancer Res. 35:232016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bak DH, Kang SH, Choi DR, Gil MN, Yu KS,
Jeong JH, Lee NS, Lee JH, Jeong YG, Kim DK, et al: Autophagy
enhancement contributes to the synergistic effect of vitamin D in
temozolomide-based glioblastoma chemotherapy. Exp Ther Med.
11:2153–2162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li C, Liu Y, Liu H, Zhang W, Shen C, Cho
K, Chen X, Peng F, Bi Y, Hou X, et al: Impact of autophagy
inhibition at different stages on cytotoxic effect of autophagy
inducer in glioblastoma cells. Cell Physiol Biochem. 35:1303–1316.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ni H, Gong Y, Yan JZ and Zhang LL:
Autophagy inhibitor 3-methyladenine regulates the expression of
LC3, Beclin-1 and ZnTs in rat cerebral cortex following recurrent
neonatal seizures. World J Emerg Med. 1:216–223. 2010.PubMed/NCBI
|
|
18
|
Xie Z and Klionsky DJ: Autophagosome
formation: Core machinery and adaptations. Nat Cell Biol.
9:1102–1109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gutierrez MG, Master SS, Singh SB, Taylor
GA, Colombo MI and Deretic V: Autophagy is a defense mechanism
inhibiting BCG and Mycobacterium tuberculosis survival in infected
macrophages. Cell. 119:753–766. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu YT, Wu MT, Lin CC, Chien CF and Tsai
TH: Pharmacokinetic studies of chinese medicinal herbs using an
automated blood sampling system and liquid chromatography-mass
spectrometry. J Tradit Complement Med. 2:33–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Inoue M, Sakuma Z, Ogihara Y and Saracoglu
I: Induction of apoptotic cell death in HL-60 cells by acteoside, a
phenylpropanoid glycoside. Biol Pharm Bull. 21:81–83. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ohno T, Inoue M, Ogihara Y and Saracoglu
I: Antimetastatic activity of acteoside, a phenylethanoid
glycoside. Biol Pharm Bull. 25:666–668. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee KJ, Woo ER, Choi CY, Shin DW, Lee DG,
You HJ and Jeong HG: Protective effect of acteoside on carbon
tetrachloride-induced hepatotoxicity. Life Sci. 74:1051–1064. 2004.
View Article : Google Scholar
|
|
24
|
Peerzada KJ, Faridi AH, Sharma L, Bhardwaj
SC, Satti NK, Shashi B and Tasduq SA: Acteoside-mediates
chemoprevention of experimental liver carcinogenesis through STAT-3
regulated oxidative stress and apoptosis. Environ Toxicol.
31:782–798. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao J, Liu T, Ma L, Yan M, Zhao Y, Gu Z
and Huang Y: Protective effect of acteoside on immunological liver
injury induced by Bacillus Calmette-Guerin plus lipopolysaccharide.
Planta Med. 75:1463–1469. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiong Q, Hase K, Tezuka Y, Tani T, Namba T
and Kadota S: Hepatoprotective activity of phenylethanoids from
Cistanche deserticola. Planta Med. 64:120–125. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Koh DS, Seo BS and Lee CH: Studies on the
in vitro induction of callus from anther culture of Abeliophyllum
distichum. J Chonbuk Natl Univ. 31:153–159. 1989.In Korean.
|
|
28
|
Würstle S, Schneider F, Ringel F, Gempt J,
Lämmer F, Delbridge C, Wu W and Schlegel J: Temozolomide induces
autophagy in primary and established glioblastoma cells in an EGFR
independent manner. Oncol Lett. 14:322–328. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Koukourakis MI, Mitrakas AG and
Giatromanolaki A: Therapeutic interactions of autophagy with
radiation and temozolomide in glioblastoma: Evidence and issues to
resolve. Br J Cancer. 114:485–496. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen Y, Gao F, Jiang R, Liu H, Hou J, Yi
Y, Kang L, Liu X, Li Y and Yang M: Down-regulation of AQP4
expression via p38 MAPK signaling in temozolomide-induced glioma
cells growth inhibition and invasion impairment. J Cell Biochem.
118:4905–4913. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annu Rev Genet.
43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bento CF, Renna M, Ghislat G, Puri C,
Ashkenazi A, Vicinanza M, Menzies FM and Rubinsztein DC: Mammalian
autophagy: How does it work? Annu Rev Biochem. 85:685–713. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Levine B, Mizushima N and Virgin HW:
Autophagy in immunity and inflammation. Nature. 469:323–335. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fulda S: Autophagy in Cancer Therapy.
Front Oncol. 7:1282017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Levy JMM, Towers CG and Thorburn A:
Targeting autophagy in cancer. Nat Rev Cancer. 17:528–542. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
White E: The role for autophagy in cancer.
J Clin Invest. 125:42–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Aoki H, Kondo Y, Aldape K, Yamamoto A,
Iwado E, Yokoyama T, Hollingsworth EF, Kobayashi R, Hess K,
Shinojima N, et al: Monitoring autophagy in glioblastoma with
antibody against isoform B of human microtubule-associated protein
1 light chain 3. Autophagy. 4:467–475. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cj P, Hv E, Vijayakurup V, R Menon G, Nair
S and Gopala S: High LC3/beclin expression correlates with poor
survival in glioma: A definitive role for autophagy as evidenced by
in vitro autophagic flux. Pathol Oncol Res. Oct 11–2017.PubMed/NCBI
|
|
39
|
Monastyrska I and Klionsky DJ: Autophagy
in organelle homeostasis: Peroxisome turnover. Mol Aspects Med.
27:483–494. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Farre JC and Subramani S: Peroxisome
turnover by micropexophagy: An autophagy-related process. Trends
Cell Biol. 14:515–523. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Singh R and Cuervo AM: Autophagy in the
cellular energetic balance. Cell Metab. 13:495–504. 2011.
View Article : Google Scholar : PubMed/NCBI
|
